Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
- Society
Magnitude 4.9 earthquake hits southern Taiwan
04/03/2025 01:25 PM - Politics
Japan, U.K., Canada express concerns over PLA drills around Taiwan
04/03/2025 01:24 PM - Society
Heavier traffic seen on Taiwan's freeways at start of Tomb Sweeping Festival
04/03/2025 12:15 PM - Society
Sunny, cloudy skies forecast for most of Taiwan Thursday, Friday
04/03/2025 11:22 AM